Amman Pharmaceutical Industries (API) was established in 1989 as one of the first pharmaceutical companies in the MENA region to pioneer the production of niche branded generics in the therapeutic areas of  Ophthalmology, ENT (Ear, Nose & Throat ) , respiratory, and Dermatology. After many years of success, API is still focused on its differentiator and proud to be a leader in the MENA region having expanded into 7 production lines producing +140 registered products, exporting to +30 markets globally, and employing +200 employees in Jordan and the region.

Manufacturing high quality products under superior production conditions is of the utmost importance to Amman Pharma and our manufacturing facilities have an exceptional compliance history with national, regional, and international regulatory authorities and agencies such as Jordan Food & Drug Administration (JFDA), Saudi Food & Drug Authority (SFDA), Gulf Health Council, International Committee of the Red Cross (ICRC), World Health Organization (WHO), Medicines and Healthcare products Regulatory Agency (MHRA), CE Mark, ISO 9001:2015 and more.